Metabolomics and Microbiomics Reveal the Cultivation-Dependent Divergence in Ginsenoside Biosynthesis and Rhizosphere Ecology of Panax ginseng
Metabolites · 18.02.2026 · 16 (2) · 138
DOI: 10.3390/metabo16020138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolites, online erschienen am 18.02.2026. Verfasst von Siqi Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Quality Assurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chine…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Scientific and technological innovation project of China Academy of Chinese Medical Sciences, Fundamental Research Funds for the Central public welfare research institutes.
Abstract (Originalsprache)
Background
Cultivation environments impose distinct abiotic and biotic stresses that act as primary drivers reshaping the metabolic profile and microbiome assembly of medicinal plants. This study investigates the impact of simulative habitat versus arched greenhouse cultivation on the synthesis of bioactive ginsenosides and the associated root microbiome structure in Panax ginseng.
Methods
A combined metabolomics and microbiomics approach was applied to compare ginsenoside accumulation and rhizosphere microbial community composition under the two cultivation modes.
Results
Ginseng from simulative habitat cultivation exhibited significantly higher ginsenoside content, particularly ginsenoside Re, compared to arched greenhouse cultivation, with this advantage being more pronounced in long-term cultivation. Microbiome profiling revealed that specific taxa, including Bradyrhizobium, were strongly enriched in simulative habitats and positively correlated with enhanced ginsenoside accumulation, suggesting a microbiome-mediated mechanism for metabolic plasticity. In contrast, arched greenhouse cultivation was associated with a more complex microbial structure characterized by increased negative interactions, which may compromise metabolic quality.
Conclusions
These findings, utilizing multi-omics correlations, provide a theoretical basis for optimizing Panax ginseng quality through ecological cultivation strategies that leverage stress-responsive microbe–metabolite interactions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory for Quality Assurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
ORCID-Profile: Dehua Wu, Binbin Yan, Chuanzhi Kang
Förderung
- National Key Research and Development Program of China
- Scientific and technological innovation project of China Academy of Chinese Medical Sciences
- Fundamental Research Funds for the Central public welfare research institutes
Zitieren
APA
Liu, S., Wu, D., Ma, W., Wang, T., Yan, B., Ge, Y., Xiong, F., Wang, H., & Kang, C. (2026). Metabolomics and Microbiomics Reveal the Cultivation-Dependent Divergence in Ginsenoside Biosynthesis and Rhizosphere Ecology of Panax ginseng. Metabolites, 16(2), 138. https://doi.org/10.3390/metabo16020138
Vancouver
Liu S, Wu D, Ma W, Wang T, Yan B, Ge Y, et al. Metabolomics and Microbiomics Reveal the Cultivation-Dependent Divergence in Ginsenoside Biosynthesis and Rhizosphere Ecology of Panax ginseng. Metabolites. 2026;16(2):138. doi:10.3390/metabo16020138
BibTeX
@article{Liu2026,
author = {Liu, Siqi and Wu, Dehua and Ma, Wenqi and Wang, Tielin and Yan, Binbin and Ge, Yang and Xiong, Feng and Wang, Hongyang and Kang, Chuanzhi},
title = {Metabolomics and Microbiomics Reveal the Cultivation-Dependent Divergence in Ginsenoside Biosynthesis and Rhizosphere Ecology of Panax ginseng},
journal = {Metabolites},
year = {2026},
volume = {16},
number = {2},
pages = {138},
doi = {10.3390/metabo16020138}
}
EUVIMED